Additionally, the device is designed to integrate with Optiscan’s cloud-based telepathology streaming platform, which allows remote consultation in real time anywhere in the world, and which is expected to be revealed by the company in mid-2025.
Optiscan said InForm could help with a shortage of pathologists in Australia and globally.
“A shortage of pathologists is such a big problem and pathologists just can’t keep up,” Farah said.
“By digitalising pathology you can outsource work to pathologists in different jurisdictions, creating centralised workflows, and getting expert opinions from anywhere in the world. The possibilities are endless.” he said.
OIL Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)